Skip to main content
Brazilian Journal of Microbiology logoLink to Brazilian Journal of Microbiology
. 2025 Aug 18;56(4):2703–2716. doi: 10.1007/s42770-025-01765-z

Secretion of serine proteases by planktonic- and biofilm-growing cells of Candida parapsilosis

Rafael M Gandra 1,2, Lucas Giovanini 1,3, Marta H Branquinha 1,3,4, André L S Santos 1,2,3,4,✉
PMCID: PMC12660596  PMID: 40826262

Abstract

Candida parapsilosis is a common cause of candidiasis worldwide, with biofilm formation and secretion of aspartic proteases (Saps) as key virulence factors. Conversely, serine protease secretion by this fungus is poorly understood. In this study, we investigated the secretion of serine-type proteases by planktonic- and biofilm-forming cells of C. parapsilosis cultured in brain heart infusion (BHI) medium. Cell-free supernatant from the reference strain (ATCC 22019) was screened against various serine protease substrates, revealing pronounced activity toward N-benzoyl-Phe-Val-Arg-pNa (0.74 nmol pNA.mg− 1.min− 1), with optimal activity at pH 9.0 and temperatures between 32 °C and 40 °C. Proteolytic activity was significantly reduced by serine protease inhibitors PMSF (32.8%), TLCK (40.2%) and benzamidine (50.7%), while inhibitors of other protease classes had no effect, confirming its serine-type specificity. Notably, serine protease activity was detected in supernatants from cells grown in BHI but absent in those cultured in albumin-supplemented yeast carbon base medium, a known inducer of Saps, suggesting culture-dependent regulation of protease expression. Serine protease activity also increased over time, rising from 0.36 pNA.mg− 1.min− 1 at 24-hour to 1.14 pNA.mg− 1.min− 1 at 72-hour. Clinical isolates of C. parapsilosis exhibited significantly higher serine protease activity than the reference strain under optimal conditions. Serine-type protease activity was also detected in the supernatant of mature biofilms, showing a correlation with metabolic activity and biomass. Infection of Galleria mellonella larvae with C. parapsilosis isolates revealed no correlation between larval mortality and serine protease production. These findings suggest that C. parapsilosis serine proteases contribute to fungal growth and biofilm development, representing potential targets for antifungal intervention.

Supplementary Information

The online version contains supplementary material available at 10.1007/s42770-025-01765-z.

Keywords: Candida parapsilosis, Serine protease, Protease inhibitors, Proliferation, Biofilm, Virulence.

Introduction

Fungal infections caused by emergent species such as Candida parapsilosis sensu stricto (C. parapsilosis) have significantly increased over the last decades [1, 2]. C. parapsilosis has a unique capacity to grow in hyperalimentation solutions, adhere to intravascular medical devices and form biofilms, making its infections particularly associated with the presence of catheters, central venous lines and parenteral nutrition systems [3–6]. Due to these characteristics, C. parapsilosis is frequently linked to healthcare-associated infections. Although some reports indicate that C. parapsilosis can surpass C. albicans in the number of infections [7–9], it generally ranks as the second or third most common species isolated in cases of invasive candidiasis across regions such as Latin America, North America, Europe and Asia [6]. To establish an infection in the host, C. parapsilosis deploys a variety of virulence attributes, including adhesins, biofilm formation and secretion of hydrolytic enzymes, which collectively enhance its pathogenicity and enable it to evade host immune defenses [10, 11].

Secreted aspartic proteases (Saps) are considered among the primary key virulence factors produced by C. parapsilosis, playing a pivotal role in its interactions with host structures and cells. These enzymes are crucial for processes such as adhesion, colonization, tissue invasion, dissemination and immune evasion [12]. However, other classes of proteases may also contribute significantly to these pathogenic mechanisms. Notably, serine-type proteases have been identified in C. albicans, C. glabrata, C. tropicalis, C. dubliniensis, C. guilliermondii and C. haemulonii species complex, and they are implicated in facilitating adhesion to and degradation of host tissues and extracellular matrix components, degrading complement system factors and immunoglobulins, breaching epidermal and epithelial barriers, and targeting immune cells such as lymphocytes and macrophages [13–15].

Although a serine protease with keratinolytic activity has previously been identified in C. parapsilosis [13], the regulation, dynamics of secretion and functional roles of serine-type proteases in this species remain poorly understood. To bridge this gap, the present study aimed to investigate the presence of secreted serine-type proteases in C. parapsilosis, with particular emphasis on their production by both planktonic and biofilm-associated cells. In parallel, an in vivo infection assay was performed using Galleria mellonella larvae as a model to investigate the potential correlation between serine protease production and fungal virulence in a living host. This model system offers a valuable platform to assess pathogenicity and host-pathogen interactions in a physiologically relevant context.

Materials and methods

Fungi and growth conditions

The reference American Type Culture Collection (ATCC 22019) strain and nine clinical isolates of C. parapsilosis [16] (kindly provided by Dr. Marcos Dornelas-Ribeiro, Instituto de Biologia do Exército, RJ, Brazil), were employed in the present study. The clinical isolates were biochemically/molecularly identified in a previous study by our group as C. parapsilosis sensu stricto (C. parapsilosis) [16] and designated as 222 (isolate recovered from toe), 225 (from toe), 229 (from a finger), 234 (unknown origin), 235 (from finger), 241 (from ear), 251 (from gluteus), 275 (form finger) and 454 (unknown origin). The fungal cells were cultured into brain heart infusion (BHI) medium for 48 h at 37 °C under constant agitation (200 rpm), a condition that induces the secretion of serine-type proteases in Candida spp [13].

Obtainment of cell-free culture supernatant

The 48-h fungal cultures were harvested by centrifugation at 4000×g for 10 min at 4 °C, and the spun culture medium was filtered through a 0.22-µm membrane (Millipore, SP, Brazil). The cell-free culture supernatants were concentrated 100-fold using a 10 kDa molecular weight cut-off AMICON micropartition system (AMICON®, Beverly, MA, USA) and stored at − 20 °C. Protein levels were quantified using the method proposed by Lowry and colleagues [17].

Cleavage of peptide substrates by cell-free supernatant

Protease activity was measured by using different chromogenic substrates of the peptidyl-p-nitroaniline (pNA) type, namely: N-Suc-Ala-Ala-Ala-pNA, a substrate for elastase; N-Suc-Gly-Gly-Phe-pNA and N-Suc-Ala-Ala-Pro-Phe-pNA, substrates for chymotrypsin; Nα-benzoyl-DL-4Arg and N-benzoyl-Phe-Val-Arg-pNA, substrates for trypsin. The substrates were diluted in dimethylsulfoxide (DMSO) at 40 mM and stored at – 20 °C. The reaction was conducted in a total volume of 200 µL, in a 96-well-plate containing the reaction solution (50 mM glycine-NaOH buffer, pH 9.0), 200 µM of the substrate, and cell-free culture supernatant (500 µg protein) from C. parapsilosis (ATCC 22019). The reaction mixture was incubated at 37 °C for 60 min and hydrolysis was measured at 405 nm using a spectrophotometer. Characterization of cell-free supernatant proteolytic activity was carried out using the substrate N-benzoyl-Phe-Val-Arg-pNA as described, under different conditions of pH using the following buffer solutions: 50 mM sodium citrate (pH 3.0–5.0), 50 mM sodium phosphate (pH 6.0–8.0) or 50 mM glycine-NaOH (pH 9.0–12.0), as well as under different temperatures (28, 32, 37 and 40 °C) using 50 mM glycine-NaOH (pH 9.0) as standard buffer. Control wells containing only the respective buffers at each pH value were included to monitor abiotic substrate degradation, and the background signal from these controls was subtracted from the experimental readings. Finally, cell-free supernatant and N-benzoyl-Phe-Val-Arg-pNA were incubated in the presence of phenylmethylsulfonyl fluoride (PMSF, 10 mM), benzamidine (10 mM), Nα-tosil-l-lysine chloromethyl ketone hydrochloride (TLCK, 10 mM), pepstatin A (PepA, 10 µM), trans-epoxysuccinyl-l-leucyl-amido(4-guanidino butane) (E-64, 10 µM) and 1,10-phenanthroline (phen, 10 mM) in 50 mM glycine-NaOH buffer, pH 9.0, as previously described.

Modulation of protease production by distinct culture media

Cell-free supernatants were obtained from cultures of C. parapsilosis (ATCC 22019) grown in BHI or yeast carbon base (YCB) medium supplemented with 0.1% bovine serum albumin (BSA), a condition known to induce Sap production, and incubated (500 µg of protein) with the chromogenic substrate N-Benzoyl-Phe-Val-Arg-pNA in 50 mM glycine-NaOH buffer, pH 9.0, as previously described, to measure serine protease activity. The supernatants were also incubated with the fluorogenic peptide substrate for cathepsin D (7-methoxycoumarin-4-acetyl-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys (DNP)-D-Arg-amide) (Sigma Chemical Co., St. Louis, USA) to measure aspartic protease activity. For this assay, the reaction was started by adding the substrate (2 µM) to each well of a 96-well plate containing the supernatant and citrate buffer, pH 4.0, in a total volume of 60 µL. The reaction mixture was incubated at 37 °C for 60 min and substrate cleavage was evaluated with a spectrofluorometer (SpectraMax Gemini XPS, Molecular Devices, CA, USA) using an excitation wavelength of 340 nm and an emission wavelength of 490 nm. The assays were controlled for self-liberation of the fluorophore over the same time interval.

Enzymatic activity of planktonic growth supernatant

C. parapsilosis (ATCC 22019) was inoculated (106 cells/mL) into a Falcon tube containing BHI broth and incubated at 37 °C under agitation. A sample of 1 mL of the culture was collected at different time points (24 h, 48 h and 72 h), and after centrifugation, the supernatant was collected. In comparison, the cells were resuspended in 1 mL of phosphate-buffered saline (PBS, 7.2), diluted, and counted using a Neubauer chamber to establish a growth curve. Protein levels in the supernatant were measured and a sample of 500 µg of protein was incubated with the substrate N-Benzoyl-Phe-Val-Arg-pNA in 50 mM glycine-NaOH buffer, pH 9.0, using the conditions previously described.

Enzymatic activity of different clinical isolates

Nine clinical isolates of C. parapsilosis and the ATCC 22019 strain were grown in BHI broth for 48 h at 37 °C under constant agitation (200 rpm), the cell-free supernatant was obtained and the protein concentration was measured. The non-concentrated supernatant containing 100 µg of proteins adjusted to 50 µL was incubated with the substrate N-Benzoyl-Phe-Val-Arg-pNA (200 µM) in 50 mM glycine-NaOH buffer, pH 9.0, as previously described, and proteolysis was determined by spectrophotometry at 405 nm after 60 min.

Enzymatic activity of mature biofilm supernatant

C. parapsilosis (ATCC 22019) (106 cells) was inoculated in 24-well polystyrene plates containing 1 mL of BHI broth in each well and incubated for 48 h at 37 °C without shaking to allow adherence and biofilm formation [16]. The supernatant was collected, centrifuged, and the protein concentration measured. The presence of enzymatic activity and its optimum pH was determined using 500 µg of proteins and the substrate N-Benzoyl-Phe-Val-Arg-pNA (200 µM), as previously described. Reactions were performed at 37 °C across a range of pH values using distinct 50 mM buffers: sodium citrate (pH 3.0–5.0), sodium phosphate (pH 6.0–8.0), and glycine–NaOH (pH 9.0–12.0).

Enzymatic activity of the supernatant during biofilm formation

C. parapsilosis (ATCC 22019) cells (106) were inoculated in different 96-well plates containing 200 µL of BHI medium in each well, and the plates were incubated at 37 °C without agitation. The assays were performed at different timepoints (24, 48, 72 and 96 h), and three parameters were analyzed: supernatant enzymatic activity, biofilm cellular viability and biofilm biomass. Enzymatic activity was determined using the collected supernatant (500 µg of protein) and the substrate N-Benzoyl-Phe-Val-Arg-pNA (200 µM) in 50 mM glycine–NaOH, pH 9.0, as previously described. The biofilm cellular viability was measured through the metabolic activity of the cells by the reduction of XTT (2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide), as previously described [18]. Shortly, the wells of the plate were washed three times with PBS, and 158 µL of PBS, 40 µL of XTT (1 mg/mL), and 2 µL menadione (0.4 mM) were added to each well. The plates were incubated for 3 h at 37 °C, away from light sources, and the reduction of XTT was measured at 492 nm in an ELISA plate reader. For biomass quantification, the wells were washed three times with PBS and 200 µL of crystal violet dye 0.4% was added to each well, and the plate was incubated at room temperature for 5 min. The wells were washed with distilled water to remove excess dye and 200 µL of absolute ethanol was added to the wells for 5 min. The bleach solution was then transferred to another 96-well plate, and the absorbance was measured at 570 nm in an ELISA reader.

Galleria mellonella assay

In this set of experiments, G. mellonella larvae weighing approximately 0.2–0.3 g and exhibiting uniform, healthy coloration were selected for use. For survival assays, fungal cells were cultured for 48 h at 37 °C in liquid BHI medium, then harvested, washed with sterile PBS, and resuspended in the same buffer. Larvae (n = 10 per group) were injected with 1 × 10⁶ fungal cells per larva through the last right proleg using a 10-µL Hamilton syringe (Hamilton Company, Reno, NV, USA), and incubated at 37 °C for up to five days. Survival was assessed daily by evaluating the larvae’s responsiveness to gentle tactile stimulation on the head and body; lack of movement was recorded as death. In addition, visual inspection of larval coloration was performed as an auxiliary indicator of physiological stress or disease progression.

Statistical analysis

All experiments were performed in triplicate, in three independent experimental sets. Statistical analyses were performed using either Student’s t-test or one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test, using GraphPad Prism 8 for Windows (GraphPad Software, La Jolla, CA, USA). In the case of the survival curve, the log-rank (Mantel-Cox) test was used to indicate statistical significance. The correlation test was determined by Pearson’s correlation coefficient (r). In all the analyses, P values of 0.05 or less were considered statistically significant.

Results

C. parapsilosis secretions cleave serine protease substrates: effects of protease inhibitors, pHs and temperatures

Initially, five chromogenic peptide substrates, with specific affinities for elastase, trypsin and chymotrypsin families of serine-type proteases, were used to assess the ability of cell-free conditioned supernatants from C. parapsilosis planktonic cells to cleave these substrates. The degradation rates of N-Suc-Gly-Gly-Phe-pNA (0.38 nmol pNA mg⁻¹ min⁻¹), N-Suc-Ala-Ala-Pro-Phe-pNA (0.41 nmol pNA mg⁻¹ min⁻¹), N-Suc-Ala-Ala-Ala-pNA (0.44 nmol pNA mg⁻¹ min⁻¹) and Nα-benzoyl-DL-4Arg (0.45 nmol pNA mg⁻¹ min⁻¹) were observed, confirming the presence of all three families of serine proteases in C. parapsilosis secretions. Notably, the cleavage rate of the N-benzoyl-Phe-Val-Arg-pNA substrate was significantly higher (0.74 nmol pNA mg⁻¹ min⁻¹) than that of the other substrates, suggesting that trypsin-like serine proteases are predominantly secreted by C. parapsilosis (Fig. 1A). As a result, this substrate was selected for further assays.

Fig. 1.

Fig. 1

Cell-free supernatants of C. parapsilosis degrade various serine protease substrates under different pH and temperature conditions. (A) Concentrated supernatant from C. parapsilosis (ATCC 22019), containing 500 µg of protein, was incubated with 200 µM chromogenic substrates specific for different serine protease classes (subtilisin-, chymotrypsin- and trypsin-like) at 37 °C in 50 mM glycine-NaOH buffer, pH 9.0. Enzymatic activity was measured spectrophotometrically at 405 nm after 60 min of incubation. The asterisk denotes a statistically significant difference in the hydrolysis of trypsin-specific substrate N-benzoyl-Phe-Val-Arg-pNA compared to the other serine-type substrates (P < 0.05, Tukey’s multiple comparisons test). (B) Hydrolysis of N-Benzoyl-Phe-Val-Arg-pNA was confirmed to be catalyzed by serine-type proteases through inhibition assays using specific inhibitors: E-64 (cysteine), pepstatin A (aspartic), 1,10-phenanthroline (metallo), and PMSF, TLCK and benzamidine (serine proteases). Asterisks denote statistically significant differences compared to the control group and the group treated with the protease inhibitor (P < 0.05, Student’s t-test). (C) A total of 500 µg of protein was incubated with 200 µM N-Benzoyl-Phe-Val-Arg-pNA across a pH range using different buffers at 50 mM: sodium citrate buffer (pH 3.0–5.0), sodium phosphate buffer (pH 6.0–8.0) and glycine-NaOH buffer (pH 9.0–12.0). (D) Substrate degradation (N-Benzoyl-Phe-Val-Arg-pNA) was also evaluated at different temperatures using 50 mM glycine-NaOH buffer, pH 9.0. The asterisk denotes a statistically significant difference in substrate hydrolysis at 28 °C compared to the other tested temperatures (P < 0.05, Tukey’s multiple comparisons test). Bars represent the mean ± standard deviation of three independent experiments

In the presence of inhibitors targeting different protease classes, a significant reduction in substrate cleavage was observed with PMSF (32.8%), TLCK (40.2%) and benzamidine (50.7%), all classical inhibitors of serine-type proteases (Fig. 1B). In contrast, no inhibition was detected with E-64 (a cysteine protease inhibitor), pepstatin A (an aspartic protease inhibitor) or 1,10-phenanthroline (a metalloprotease inhibitor), further confirming the specificity of serine-type proteases in the observed activity (Fig. 1B).

Serine-type proteolytic activity was observed across a broad pH range, from 6.0 (0.05 nmol pNA mg⁻¹ min⁻¹) to 12.0 (0.27 nmol pNA mg⁻¹ min⁻¹), with optimal activity at pH 9.0 (0.74 nmol pNA mg⁻¹ min⁻¹) (Fig. 1C). Similarly, proteolytic activity was detected across a wide temperature range (28 °C to 40 °C), peaking at 32 °C (0.75 nmol pNA mg⁻¹ min⁻¹) (Fig. 1D).

Culture media influence the secretion of proteases by C. parapsilosis cells

Distinct proteolytic activities were observed in the supernatants of C. parapsilosis cultured in BHI and YCB-BSA media. Minimal substrate cleavage of the cathepsin D (aspartic protease) substrate was detected in the BHI-derived supernatant (0.05 fluorescent arbitrary units), while significantly higher proteolysis was observed with the YCB-BSA-derived supernatant (0.68 fluorescent arbitrary units) (Fig. 2A). In contrast, when using the serine protease substrate N-benzoyl-Phe-Val-Arg-pNA, the BHI-derived supernatant exhibited high levels of substrate degradation (0.74 nmol pNA mg⁻¹ min⁻¹). In comparison, the YCB-BSA-derived supernatant displayed considerably lower proteolytic activity (0.08 nmol pNA mg⁻¹ min⁻¹) (Fig. 2B).

Fig. 2.

Fig. 2

Culture medium composition modulates protease secretion in C. parapsilosis. Fungal cells (ATCC 22019) were cultured into BHI and YCB supplemented with 0.1% BSA, and incubated for 48 h at 37 °C under constant agitation. (A) Cell-free supernatants (500 µg of protein) were incubated with 2 µM of the fluorogenic substrate 7-methoxycoumarin-4-acetyl-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys (DNP)-D-Arg-amide in 50 mM sodium citrate buffer (pH 4.0), and (B) with 200 µM of the chromogenic substrate N-Benzoyl-Phe-Val-Arg-pNA in 50 mM glycine-NaOH buffer (pH 9.0), both for 60 min at 37 °C. Enzymatic activities were measured by spectrophotometry at 405 nm for the serine protease substrate, and by spectrofluorometry using an excitation wavelength of 340 nm and an emission wavelength of 490 nm for the aspartic protease substrate. Bars represent the mean ± standard deviation of three independent experiments. Asterisks denote statistically significant differences between the two systems (P < 0.05, Student’s t-test). FAU = Fluorescent arbitrary units

C. parapsilosis growth impacts protease activity level

The cellular proliferation of C. parapsilosis was measured at various time points, revealing a typical growth curve in which cell density increased steadily from 24 h (9.5 × 10⁶ cells/mL) to 72 h (39.5 × 10⁶ cells/mL) of incubation in BHI medium, followed by a slight decline at 96 h (36.5 × 10⁶ cells/mL) (Fig. 3A). In parallel, the degradation of N-benzoyl-Phe-Val-Arg-pNA by C. parapsilosis secretions was observed at all time points. Consistent with the growth curve, enzymatic activity peaked at 72 h (1.14 nmol pNA mg⁻¹ min⁻¹) before decreasing at 96 h (0.97 nmol pNA mg⁻¹ min⁻¹) (Fig. 3B).

Fig. 3.

Fig. 3

Evaluation of serine protease activity during planktonic growth of C. parapsilosis. Fungal cells (ATCC 22019) were inoculated into 20 mL of BHI medium (1 × 10⁶ cells/mL), and incubated at 37 °C under constant agitation. At 24, 48, 72 and 96 h, 1 mL aliquots were collected, centrifuged, and the supernatant harvested for analysis. (A) Cell density at each time point was determined using a Neubauer chamber to construct a growth curve. (B) The supernatant from each time point was concentrated and then incubated (500 µg of protein) with 200 µM N-Benzoyl-Phe-Val-Arg-PNA in 50 mM glycine-NaOH buffer, pH 9.0, at 37 °C for 60 min, followed by spectrophotometric measurement of enzymatic activity. Bars represent the mean ± standard deviation of three independent experiments. Symbols indicate statistically significant differences according to Tukey’s multiple comparisons test, as follows: (*, P < 0.05 or **, P < 0.001) denote significant differences between 24 h and 48, 72–96 h; (♦, P < 0.05) indicates significant differences between 48 h and 72–96 h; and (◼) indicates a significant difference between 72 h and 96 h

Serine proteolytic activity in various C. parapsilosis clinical isolates

Conditioned supernatants (100 µg of protein) from nine different clinical isolates of C. parapsilosis were tested for their ability to cleave the substrate N-Benzoyl-Phe-Val-Arg-pNA without prior concentration. All isolates demonstrated substrate degradation, albeit at varying intensities (Fig. 4). The levels of substrate degradation observed with the ATCC 22019 strain using 100 µg of protein were comparable to those obtained in previous assays with 500 µg, suggesting that substrate saturation had already been reached at the lower protein concentration. Remarkably, all clinical isolates of C. parapsilosis exhibited significantly higher degradation efficiency against the serine-type protease substrate compared to the reference strain ATCC 22019, with the following results: 83.7% (strain 251), 114.8% (strain 241), 243.2% (strains 454 and 225), 291.9% (strain 235), 297.3% (strain H234), 328.3% (strain 276), 331% (strain 222) and 423% (strain 275). Notably, strain 275 displayed the highest serine protease activity, significantly surpassing the other strains.

Fig. 4.

Fig. 4

Comparison of serine-type protease activity in cell-free supernatants from different clinical isolates of C. parapsilosis. Cell-free supernatants were collected from nine clinical isolates and the reference strain ATCC 22019 after cultivation in 10 mL of BHI medium at 37 °C for 48 h under constant agitation. Following centrifugation, protein concentrations were determined, and 100 µg of protein from each sample was incubated with 200 µM N-benzoyl-Phe-Val-Arg-PNA in 50 mM glycine-NaOH buffer, pH 9.0, at 37 °C for 60 min. Enzymatic activity was assessed spectrophotometrically at 405 nm. Bars represent the mean ± standard deviation of three independent experiments. Symbols (*, P < 0.05 or **, P < 0.001) indicate statistically significant differences in serine-type protease production between the reference strain ATCC 22019 and clinical isolates of C. parapsilosis, as determined by Tukey’s multiple comparisons test

Serine-type protease activity during biofilm formation

The supernatant obtained from C. parapsilosis biofilm also demonstrated the ability to degrade N-Benzoyl-Phe-Val-Arg-pNA across a range of pH values, from pH 6.0 (0.094 nmol pNA mg⁻¹ min⁻¹) to pH 12.0 (0.255 nmol pNA mg⁻¹ min⁻¹) (Fig. 5). Over time, proteolytic activity showed a progressive increase, from 0.20 to 0.36, 0.43 and 0.54 nmol pNA mg⁻¹ min⁻¹ at 24, 48, 72 and 96 h, respectively (Fig. 6A). Similarly, biofilm viability increased over time, rising by 31% at 48 h (absorbance = 1.71) and by 79.5% at 72 h (absorbance = 2.35) compared to the initial 24-h measurement (absorbance = 1.30), reaching a significant peak. However, after 96 h, viability declined by 21.77% (absorbance = 1.02) relative to the 24-h point (Fig. 6B). Additionally, biofilm biomass also increased over time, becoming 46.5% denser after 96 h (absorbance = 0.142) compared to 24 h (absorbance = 0.076) (Fig. 6C).

Fig. 5.

Fig. 5

Influence of pH on serine protease activity in cell-free supernatants from biofilm-forming C. parapsilosis cells. Fungal cells (ATCC 22019) at 1 × 10⁶ cells per well were inoculated into 24-well polystyrene plates containing 1 mL of BHI medium and incubated for 48 h at 37 °C without agitation to promote adherence and biofilm formation. After incubation, supernatants were collected and protein concentrations determined. Supernatants (500 µg protein) were incubated with 200 µM N-benzoyl-Phe-Val-Arg-pNA in 50 mM glycine-NaOH buffer, pH 9.0, at 37 °C for 60 min in buffers spanning different pH ranges: 50 mM sodium citrate (pH 3.0–5.0), 50 mM sodium phosphate (pH 6.0–8.0) and 50 mM glycine–NaOH (pH 9.0–12.0). Enzymatic activity was measured spectrophotometrically at 405 nm. Bars represent the mean ± standard deviation of three independent experiments

Fig. 6.

Fig. 6

Comparison of serine protease activity, cellular viability and biomass levels at different time points during biofilm formation of C. parapsilosis cells on polystyrene. C. parapsilosis (ATCC 22019) was inoculated (1 × 10⁶ cells) into each well of a 96-well plates containing 200 µL of BHI medium and incubated at 37 °C. At 24, 48, 72 and 96 h, supernatants were collected, centrifuged, and used for assays. (A) Serine protease activity was assessed by incubating 500 µg of protein from supernatants with 200 µM N-benzoyl-Phe-Val-Arg-pNA in 50 mM glycine-NaOH buffer, pH 9.0, at 37 °C for 60 min, followed by spectrophotometric measurement at 405 nm. (B) Biofilm cellular viability was determined by metabolic activity using the XTT reduction assay. (C) Biofilm biomass was quantified via staining with 0.4% crystal violet dye. Bars represent the mean ± standard deviation of three independent experiments. Symbols indicate statistically significant differences (P < 0.05) according to Tukey’s multiple comparisons test, as follows: (*) denotes significant differences between 24 h and 48, 72–96 h; (♦) indicates significant differences between 48 h and 72–96 h; and (◼) indicates a significant difference between 72 h and 96 h

In vivo infection in G. mellonella

Overall, the in vivo infection assay demonstrated that all C. parapsilosis isolates induced high levels of larval mortality by 96 h post-infection (Fig. 7). However, no significant correlation was found between the rate of larval death and the level of serine protease production by the fungal isolates (P > 0.05, Pearson correlation test). Despite this, clear isolate-dependent differences in virulence were observed. For example, at 24 h post-infection, isolate 225 was the most virulent, causing 50% larval mortality. In contrast, isolates 234 and 241 each killed 30% of larvae, isolates 275 and 454 killed 20%, and isolate 276 caused 10% mortality. At this same time point, isolates 222, 235, 251 and the ATCC reference strain did not kill any larvae, with mortality rates significantly lower than that of isolate 225 (P < 0.05, Mantel-Cox test) (Fig. 7). By 48 h post-infection, isolates 234, 241 and 251 had killed all larvae, while isolates 225, 275 and 454 reached 100% lethality by 72 h. The remaining fungal isolates exhibited larval mortality ranging from 80 to 90% by the end of the experimental period (Fig. 7).

Fig. 7.

Fig. 7

Comparison of the virulence of C. parapsilosis isolates in the Galleria mellonella infection model. Larvae were inoculated with 1 × 10⁶ fungal cells per larva and incubated at 37 °C for up to 4 days. Survival rates are expressed as the percentage of surviving larvae relative to the uninfected control group (PBS-treated)

Discussion

The incidence of fungal infections has significantly increased, leading to higher rates of morbidity and mortality, particularly among immunocompromised individuals [1]. Notably, non-albicans Candida species, such as C. parapsilosis, are becoming more commonly isolated from patients with systemic fungal infections [12]. Several virulence factors contribute to the establishment of infection, with hydrolytic enzymes playing a key role in this process. While the contributions of secreted aspartic proteases (Saps) to the physiology and virulence of Candida have been well-documented [19, 20], very little is known about the role of serine proteases. It has been suggested that serine proteases can degrade serum proteins and components of the extracellular matrix, aiding in breaching host barriers and facilitating the attack on macrophages and lymphocytes [13–16, 21]. This suggests that serine proteases could serve as potential targets for novel therapeutic interventions. However, research on the production of serine proteases by C. parapsilosis remains limited. In this study, we aimed to evaluate the secretion and activity of these proteases in both planktonic and biofilm-growing C. parapsilosis cells.

The cell-free supernatant of C. parapsilosis exhibited the ability to cleave various peptidyl-pNA chromogenic substrates specific to different serine protease classes, including subtilisin, trypsin and chymotrypsin. However, significantly higher levels of degradation of the N-Benzoyl-Phe-Val-Arg-pNA substrate suggest that trypsin-like serine proteases are predominantly secreted by C. parapsilosis. This is further supported by the lack of inhibition from metallo, cysteine or aspartic protease inhibitors, and a marked reduction in proteolytic activity when exposed to classical serine protease inhibitors like PMSF, as well as specific trypsin-like protease inhibitors, such as TLCK and benzamidine. The production of trypsin-like serine proteases has been documented in various fungal species [22–26], with the expression of these proteases often linked to fungal pathogenesis [27–29]. It has been previously reported that species within the emerging pathogenic C. haemulonii complex secrete serine-type proteases that exhibit activity across a broad range of pH levels and temperatures, as well as against various substrates. Interestingly, high levels of substrate degradation of N-Benzoyl-Phe-Val-Arg-pNA at alkaline pH, which is significantly inhibited by trypsin inhibitors such as PMSF and AEBSF, suggest that, similar to our observations with C. parapsilosis, the C. haemulonii complex primarily secretes trypsin-like serine proteases [21, 30]. Notably, trypsin inhibitors have been shown to induce significant morphological changes, alter plasma membrane integrity, reduce intracellular ATP levels, promote lipid peroxidation and inhibit the proliferation of medically relevant Candida species, such as C. albicans, C. krusei and C. tropicalis [31, 32]. Previous studies from our group have demonstrated that the serine protease inhibitor TPCK can trigger a range of morphophysiological changes and interfere with virulence traits in C. parapsilosis and C. haemulonii [33, 34]. Collectively, these findings highlight the crucial role of trypsin-like serine proteases in C. parapsilosis biology and virulence, underscoring the need for further investigation into the dynamics of their production and activity.

During its life cycle, C. parapsilosis is exposed to various stressors, including fluctuations in environmental pH and temperature. Its ability to adapt to these changing conditions is a critical factor for successful host colonization and establishing infection. This adaptability enables the organism to thrive in diverse environments, enhancing its virulence and persistence in the host [35, 36]. This evolutionary adaptation likely explains the thermal stability and the broad pH range over which we observed substrate degradation. The adaptability of serine proteases to diverse environmental conditions is a widespread phenomenon, and has been documented across a variety of organisms, including bacteria, fungi and mammalian tissues. This versatility is essential for survival in fluctuating environments and plays a significant role in the pathogenesis of many microbial species [37–40]. The alkaline pH (pH 9.0), at which optimal substrate degradation was observed, also appears to be a common characteristic of many pathogenic fungal species, including C. albicans, Scedosporium apiospermum, Cryptococcus neoformans, Trichophyton rubrum, Coccidioides immitis, Microsporum canis, Histoplasma capsulatum, Aspergillus niger, Aspergillus flavus and Aspergillus fumigatus. This feature is not limited to pathogenic fungi, as it has also been observed in non-pathogenic species such as Aspergillus clavatus, Conidiobolus coronatus, Rhizopus oligosporus, Trichoderma harzianum and Cephalosporium sp. This shared trait underscores the evolutionary significance of alkaline tolerance in fungi, particularly for those involved in pathogenic interactions [41–48]. It is noteworthy that a previous study identified a serine protease secreted by C. parapsilosis with an optimal activity pH of 5.5 [49]. This difference in pH preference could be attributed to variations in culture conditions and the nutrient composition of the culture medium, both of which are known to influence protease expression [50, 51]. Our data corroborates this, demonstrating a predominance of serine proteases secreted into BHI culture medium, while their expression was repressed when YCB supplemented with 0.1% BSA was used, favoring the secretion of aspartic proteases. This observation aligns with previous research showing that when C. albicans is cultivated in a defined medium with BSA or hemoglobin as a nitrogen source, Saps’ expression is predominant, whereas in BHI broth or RPMI, serine and metalloproteases become more prevalent [52, 53]. It has been suggested that this phenomenon may be modulated by factors such as the molecular mass of proteins in the culture medium, pH, metal ions and incubation time, although the precise mechanisms remain unclear [52, 54, 55].

When comparing the ability to cleave the substrate N-Benzoyl-Phe-Val-Arg-pNA, we found that the supernatant from the reference strain of C. parapsilosis (ATCC 22019) exhibited significantly lower proteolytic activity than several clinical isolates. Remarkably, all of the more recently isolated clinical samples displayed much higher proteolytic activity. This suggests that these proteases could play a crucial role in the interaction between the pathogen and the host during the infection process. Similar trends have been observed in other human fungal pathogens, such as C. neoformans, C. albicans, Paracoccidiodes brasiliensis and Blastomyces dermatitidis, where more recently isolated strains tend to be more virulent than older strains. Prolonged in vitro cultivation of these pathogens often leads to a reduction in virulence, which can be restored after passage through an in vivo model. This further highlights the potential link between proteolytic activity and the pathogenicity of these clinical isolates [56–60]. Additionally, studies have shown that more recently isolated samples of Fonsecaea pedrosoi exhibit significantly higher Sap activity compared to older strains. Similarly, the production of Saps in C. albicans is notably increased after passage through a murine model. These findings further underscore the potential role of protease activity in the virulence and pathogenicity of fungal pathogens, suggesting that protease expression may be modulated in response to environmental factors, such as host interactions, which could enhance the fungal ability to cause infection [50, 61, 62]. Our data indicate that serine protease levels are significantly higher in more recently isolated samples, suggesting that these proteases may play a crucial role in the colonization process and in the establishment of infection within the host.

We observed a peak in secreted proteolytic activity in the supernatant that coincided with the highest cellular density during planktonic growth, suggesting a role for these serine proteases in C. parapsilosis proliferation. This finding is consistent with the established role of fungal proteases in various essential biological processes, including nutrient acquisition, cellular growth and proliferation. Proteolytic activity likely facilitates the breakdown of host proteins and extracellular matrix components, contributing to the pathogen’s ability to proliferate and thrive in diverse environments [63, 64]. It is noteworthy that serine protease activity increased over time during biofilm formation, following a trend that paralleled the increase in cellular viability up to 72 h. The peak of serine protease activity coincided with the highest biomass levels. This is significant, as C. parapsilosis is known for its ability to adhere to medical devices and form biofilms, structured communities of cells encased in an extracellular matrix, which significantly enhances the resistance of fungal cells to antifungal treatments and the host immune response [4, 65]. The production of Saps during Candida biofilm formation is dynamic and variable. For example, upregulation of the SAP1, SAP2, SAP4, SAP5, SAP6, SAP9 and SAP10 genes during C. albicans biofilm formation has been reported [65–72]. Disruption of SAP5, SAP6, SAP9 and SAP10 genes reduces its biofilm, while deletion of SAP9 alters the biofilm architecture [66, 73]. In contrast, C. tropicalis does not exhibit increased expression of SAP1, SAP2 and SAP4 during biofilm formation, and even shows decreased expression of SAP3 [69]. In C. parapsilosis, reduced levels of Sap1 and Sap2 have been reported in the supernatant of cells growing in a biofilm [19], while Candida auris mutants deficient in SAP2 and SAP6 exhibit impaired biofilm formation [74]. These data demonstrate differential expression of Saps in biofilm formation, suggesting a probable role for the enzymes in biofilm development. However, while the involvement of serine proteases in bacterial biofilm formation has been well documented [75, 76], the specific role of secreted serine proteases in C. parapsilosis biofilm formation remains unclear. In a previous work, we demonstrated that the serine protease inhibitor TPCK can reduce cellular viability and partially disrupt mature biofilms of C. parapsilosis [33]. Similarly, TPCK has been shown to inhibit biofilm formation in C. albicans [77]. These findings, combined with the data from this study, strongly suggest that serine proteases play a crucial role in biofilm formation, a key virulence factor for Candida species [77]. More importantly, biofilm formation is essential for C. parapsilosis’s ability to establish infections [78, 79], particularly in medical devices and parenteral nutrition systems, areas where this pathogen is particularly problematic [78, 79]. Consequently, targeting serine proteases could be a promising strategy to prevent biofilm formation and mitigate the risk of C. parapsilosis infections in clinical settings.

In conclusion, the cell-free culture supernatant of C. parapsilosis demonstrates the ability to cleave various substrates, with a significantly higher affinity for the serine-type protease substrate N-Benzoyl-Phe-Val-Arg-PNA. The observed serine-type proteolytic activity appears to be primarily mediated by an alkaline, trypsin-like serine protease that demonstrates remarkable tolerance to variations in pH and temperature. Additionally, the production of this protease is modulated by the composition of the culture medium. The serine proteases secreted by C. parapsilosis are implicated in both cellular proliferation and biofilm formation, processes critical for the pathogen’s ability to interact with the host. Notably, higher levels of serine protease production were observed in the more recently isolated clinical specimens, suggesting a potential role for these enzymes in promoting infection and enhancing virulence. However, this hypothesis was not supported by the in vivo G. mellonella infection model, as all C. parapsilosis isolates tested in this study exhibited comparable levels of virulence. In this context, high larval mortality rates were observed across isolates, with significant lethality occurring after 96 h post-infection. These findings indicate that, although protease production may contribute to pathogenicity, it is not the sole determinant of virulence in this model system. Nevertheless, our findings, in conjunction with previous data demonstrating reduced virulence upon treatment with the serine protease inhibitor TPCK [33], support the notion that secreted serine-type proteases represent promising molecular targets for the development of novel antifungal strategies aimed at mitigating infections caused by this opportunistic pathogen. Although we did not directly identify or characterize the specific protease responsible for the observed activity, which can be considered an acknowledged limitation of our study, these findings open new avenues for future research aimed at the identification, biochemical characterization, and functional analysis of serine proteases in this opportunistic fungal pathogen.

Supplementary Information

Below is the link to the electronic supplementary material.

Acknowledgements

This work was supported by grants from the Brazilian Agencies: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa no Estado do Rio de Janeiro (FAPERJ) and Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES – financial support 001). The authors are grateful to Lucieri Olegario Pereira Souza and Denise da Rocha de Souza for providing technical support during the larvae experiments.

Author contributions

Rafael Gandra (Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft), Lucas Giovanini (Formal analysis, Investigation, Methodology, Writing - original draft), Marta Branquinha (Conceptualization, Data curation, Formal analysis, Funding acquisition, Supervision, Writing - review & editing), André Santos (Conceptualization, Data curation, Formal analysis, Funding acquisition, Project administration, Supervision, Writing - review & editing).

Declarations

Competing interests

Authors have no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Soriano A, Honore PM, Puerta-Alcalde P, Garcia-Vidal C, Pagotto A, Goncalves-Bradley DC et al (2023) Invasive candidiasis: current clinical challenges and unmet needs in adult populations. J Antimicrob Chemother 78(7):1569–1585. 10.1093/jac/dkad139 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Daneshnia F, de Almeida Junior JN, Ilkit M, Lombardi L, Perry AM, Gao M et al (2023) Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. Lancet Microbe 4(6):e470–e80. 10.1016/S2666-5247(23)00067-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.De Carolis E, Soldini S, La Rosa M, Nucci F, Posteraro B, Sanguinetti M (2019) BIOF-HILO assay: a new MALDI-TOF mass spectrometry based method for discriminating between high- and low-biofilm-producing Candida parapsilosis isolates. Front Microbiol. ;10:2046. 10.3389/fmicb.2019.02046 [DOI] [PMC free article] [PubMed]
  • 4.Borges KRA, Pimentel IV, Lucena L, Silva M, Monteiro SG, Monteiro CA et al (2018) Adhesion and biofilm formation of Candida parapsilosis isolated from vaginal secretions to copper intrauterine devices. Rev Inst Med Trop Sao Paulo 60:e59. 10.1590/S1678-9946201860059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lattif AA, Mukherjee PK, Chandra J, Swindell K, Lockhart SR, Diekema DJ et al (2010) Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis. Int J Med Microbiol 300(4):265–270. 10.1016/j.ijmm.2009.09.001 [DOI] [PubMed] [Google Scholar]
  • 6.Branco J, Miranda IM, Rodrigues AG (2023) Candida parapsilosis virulence and antifungal resistance mechanisms: a comprehensive review of key determinants. J Fungi (Basel) 9(1). 10.3390/jof9010080 [DOI] [PMC free article] [PubMed]
  • 7.Barbedo LS, Vaz C, Pais C, Figueiredo-Carvalho MHG, Muniz MM, Zancope-Oliveira RM et al (2015) Different scenarios for Candida parapsilosis fungaemia reveal high numbers of mixed C. parapsilosis and Candida orthopsilosis infections. J Med Microbiol 64(Pt 1):7–17. 10.1099/jmm.0.080655-0 [DOI] [PubMed] [Google Scholar]
  • 8.Ozsevik SN, Sensoy G, Karli A, Albayrak C, Dagdemir A, Belet N et al (2015) Invasive fungal infections in children with hematologic and malignant diseases. J Pediatr Hematol Oncol 37(2):e69–72. 10.1097/MPH.0000000000000225 [DOI] [PubMed] [Google Scholar]
  • 9.Montagna MT, Giglio O, Napoli C, Lovero G, Caggiano G, Delia M et al (2012) Invasive fungal infections in patients with hematologic malignancies (aurora project): lights and shadows during 18-months surveillance. Int J Mol Sci 13(1):774–787. 10.3390/ijms13010774 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Mroczynska M, Brillowska-Dabrowska A (2021) Virulence of clinical Candida isolates. Pathogens 10(4). 10.3390/pathogens10040466 [DOI] [PMC free article] [PubMed]
  • 11.Branco J, Martins-Cruz C, Rodrigues L, Silva RM, Araujo-Gomes N, Goncalves T et al (2021) The transcription factor Ndt80 is a repressor of Candida parapsilosis virulence attributes. Virulence 12(1):601–614. 10.1080/21505594.2021.1878743 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Toth R, Nosek J, Mora-Montes HM, Gabaldon T, Bliss JM, Nosanchuk JD et al (2019) Candida parapsilosis: from genes to the bedside. Clin Microbiol Rev 32(2). 10.1128/CMR.00111-18 [DOI] [PMC free article] [PubMed]
  • 13.Santos ALS, Soares RMA (2005) Candida guilliermondii isolated from HIV-infected human secretes a 50 kDa serine proteinase that cleaves a broad spectrum of proteinaceous substrates. FEMS Immunol Med Microbiol 43(1):13–20. 10.1016/j.femsim.2004.06.022 [DOI] [PubMed] [Google Scholar]
  • 14.Portela MB, Souza IP, Abreu CM, Bertolini M, Holandino C, Alviano CS et al (2010) Effect of serine-type protease of Candida spp. isolated from linear gingival erythema of HIV-positive children: critical factors in the colonization. J Oral Pathol Med 39(10):753–760. 10.1111/j.1600-0714.2010.00906.x [DOI] [PubMed] [Google Scholar]
  • 15.Parnanen P, Meurman JH, Nikula-Ijas P (2015) A novel Candida glabrata cell wall associated serine protease. Biochem Biophys Res Commun 457(4):676–680. 10.1016/j.bbrc.2015.01.047 [DOI] [PubMed] [Google Scholar]
  • 16.Abi-Chacra EA, Souza LO, Cruz LP, Braga-Silva LA, Goncalves DS, Sodre CL et al (2013) Phenotypical properties associated with virulence from clinical isolates belonging to the Candida parapsilosis complex. FEMS Yeast Res 13(8):831–848. 10.1111/1567-1364.12092 [DOI] [PubMed] [Google Scholar]
  • 17.Lowry O, Rosebrough N, Farr AL, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275. 10.1016/s0021-9258(19)52451-6 [PubMed] [Google Scholar]
  • 18.Gandra RM, Mc Carron P, Fernandes MF, Ramos LS, Mello TP, Aor AC et al (2017) Antifungal potential of copper(II), manganese(II) and silver(I) 1,10-phenanthroline chelates against multidrug-resistant fungal species forming the Candida haemulonii complex: impact on the planktonic and biofilm lifestyles. Front Microbiol 8:1257. 10.3389/fmicb.2017.01257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gandra RM, Ramos LS, Cruz LPS, Souza LOP, Branquinha MH, Santos ALS (2024) Candida parapsilosis: heterogeneous and strain-specific expression of secreted aspartic proteases (Sapp1 and Sapp2). Med Mycol 62(7). 10.1093/mmy/myae066 [DOI] [PubMed]
  • 20.Yike I (2011) Fungal proteases and their pathophysiological effects. Mycopathologia 171(5):299–323. 10.1007/s11046-010-9386-2 [DOI] [PubMed] [Google Scholar]
  • 21.Souto XM, Ramos LS, Branquinha MH, Santos ALS (2019) Identification of cell-associated and secreted serine-type peptidases in multidrug-resistant emergent pathogens belonging to the Candida haemulonii complex. Folia Microbiol (Praha) 64(2):245–255. 10.1007/s12223-018-0651-y [DOI] [PubMed] [Google Scholar]
  • 22.Paterson IC, Charnley AK, Cooper RM, Clarkson JM (1993) Regulation of production of a trypsin-like protease by the insect pathogenic fungus metarhizium-anisopliae. FEMS Microbiol Lett 109(2–3):323–327. 10.1016/0378-1097(93)90040-9 [Google Scholar]
  • 23.Dobinson KF, Lecomte N, Lazarovits G (1997) Production of an extracellular trypsin-like protease by the fungal plant pathogen Verticillium dahliae. Can J Microbiol 43(3):227–233. 10.1139/m97-031 [DOI] [PubMed] [Google Scholar]
  • 24.Barata RA, Andrade MHG, Rodrigues RD, Castro IM (2002) Purification and characterization of an extracellular trypsin-like protease of Fusarium oxysporum var. Lini. J Biosc Bioengin 94(4):304–308. 10.1016/s1389-1723(02)80168-2 [DOI] [PubMed] [Google Scholar]
  • 25.Suarez B, Rey M, Castillo P, Monte E, Llobell A (2004) Isolation and characterization of PRA1, a trypsin-like protease from the biocontrol agent Trichoderma Harzianum CECT 2413 displaying nematicidal activity. Appl Microbiol Biotechnol 65(1):46–55. 10.1007/s00253-004-1610-x [DOI] [PubMed] [Google Scholar]
  • 26.Dienes D, Börjesson J, Hägglund P, Tjerneld F, Lidén G, Réczey K et al (2007) Identification of a trypsin-like serine protease from Trichoderma reesei QM9414. Enz. Microbial. Technol. ;40(5):1087-94. 10.1016/j.enzmictec.2006.08.013
  • 27.Dubovenko AG, Dunaevsky YE, Belozersky MA, Oppert B, Lord JC, Elpidina EN (2010) Trypsin-like proteins of the fungi as possible markers of pathogenicity. Fungal Biol 114(2–3):151–159. 10.1016/j.funbio.2009.11.004 [DOI] [PubMed] [Google Scholar]
  • 28.Leger RJS, Joshi L, Roberts DW (1997) Adaptation of proteases and carbohydrates of saprophytic, phytopathogenic and entomopathogenic fungi to the requirements of their ecological niches. Microbiology 143(Pt 6):1983–1992. 10.1099/00221287-143-6-1983 [DOI] [PubMed] [Google Scholar]
  • 29.Muszewska A, Stepniewska-Dziubinska MM, Steczkiewicz K, Pawlowska J, Dziedzic A, Ginalski K (2017) Fungal lifestyle reflected in serine protease repertoire. Sci Rep 7(1):9147. 10.1038/s41598-017-09644-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Souto XM, Branquinha MH, Santos ALS (2019) Chymotrypsin- and trypsin-like activities secreted by the multidrug-resistant yeasts forming the Candida haemulonii complex. Acad Bras Cienc 91(3):e20180735. 10.1590/0001-3765201920180735 [DOI] [PubMed] [Google Scholar]
  • 31.Patriota LL, Procopio TF, de Souza MF, de Oliveira AP, Carvalho LV, Pitta MG et al (2016) A trypsin inhibitor from Tecoma stans leaves inhibits growth and promotes ATP depletion and lipid peroxidation in Candida albicans and Candida Krusei. Front Microbiol 7:611. 10.3389/fmicb.2016.00611 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.de Oliveira CFR, Oliveira CT, Taveira GB, de Oliveira Mello E, Gomes VM, Macedo MLR (2018) Characterization of a Kunitz trypsin inhibitor from Enterolobium Timbouva with activity against Candida species. Int J Biol Macromol 119:645–653. 10.1016/j.ijbiomac.2018.07.034 [DOI] [PubMed] [Google Scholar]
  • 33.Gandra RM, Silva LN, Souto XM, Sangenito LS, Cruz LPS, Braga-Silva LA et al (2019) The serine peptidase inhibitor TPCK induces several morphophysiological changes in the opportunistic fungal pathogen Candida parapsilosis sensu stricto. Med Mycol 57(8):1024–1037. 10.1093/mmy/myz008 [DOI] [PubMed] [Google Scholar]
  • 34.Souto XM, Ramos LS, Oliveira SSC, Branquinha MH, Santos ALS (2021) The serine peptidase inhibitor N-rho-tosyl-l-phenylalanine chloromethyl ketone (TPCK) affects the cell biology of Candida haemulonii species complex. Fungal Biol 125(5):378–388. 10.1016/j.funbio.2020.12.004 [DOI] [PubMed] [Google Scholar]
  • 35.Davis DA (2009) How human pathogenic fungi sense and adapt to pH: the link to virulence. Curr Opin Microbiol 12(4):365–370. 10.1016/j.mib.2009.05.006 [DOI] [PubMed] [Google Scholar]
  • 36.Robert V, Cardinali G, Casadevall A (2015) Distribution and impact of yeast thermal tolerance permissive for mammalian infection. BMC Biol 13:18. 10.1186/s12915-015-0127-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Chin C-Y, Othman R, Nathan S (2007) The Burkholderia pseudomallei serine protease MprA is autoproteolytically activated to produce a highly stable enzyme. Enz Microb Technol 40(2):370–377. 10.1016/j.enzmictec.2006.09.014 [Google Scholar]
  • 38.Hajji M, Kanoun S, Nasri M, Gharsallah N (2007) Purification and characterization of an alkaline serine-protease produced by a new isolated Aspergillus clavatus ES1. Process Biochem 42(5):791–797. 10.1016/j.procbio.2007.01.011 [Google Scholar]
  • 39.Hernández-Martínez R, Gutiérrez-Sánchez G, Bergmann CW, Loera-Corral O, Rojo-Domínguez A, Huerta-Ochoa S et al (2011) Purification and characterization of a thermodynamic stable Serine protease from Aspergillus fumigatus. Process Biochem 46(10):2001–2006. 10.1016/j.procbio.2011.07.013 [Google Scholar]
  • 40.Jayakumar R, Jayashree S, Annapurna B, Seshadri S (2012) Characterization of thermostable Serine alkaline protease from an alkaliphilic strain Bacillus pumilus MCAS8 and its applications. Appl Biochem Biotechnol 168(7):1849–1866. 10.1007/s12010-012-9902-6 [DOI] [PubMed] [Google Scholar]
  • 41.Zhu WS, Wojdyla K, Donlon K, Thomas PA, Eberle HI (1990) Extracellular proteases of Aspergillus flavus. Fungal keratitis, proteases, and pathogenesis. Diagn Microbiol Infect Dis 13(6):491–497. 10.1016/0732-8893(90)90081-6 [DOI] [PubMed] [Google Scholar]
  • 42.Hogan LH, Klein BS, Levitz SM (1996) Virulence factors of medically important fungi. Clin Microbiol Rev 9(4):469–488. 10.1128/CMR.9.4.469 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Larcher G, Cimon B, Symoens F, Tronchin G, Chabasse D, Bouchara JP (1996) A 33 kDa serine proteinase from Scedosporium apiospermum. Biochem J. ;315 (Pt 1)(Pt 1):119 – 26. 10.1042/bj3150119 [DOI] [PMC free article] [PubMed]
  • 44.Monod M, Capoccia S, Lechenne B, Zaugg C, Holdom M, Jousson O (2002) Secreted proteases from pathogenic fungi. Int J Med Microbiol 292(5–6):405–419. 10.1078/1438-4221-00223 [DOI] [PubMed] [Google Scholar]
  • 45.Rodrigues ML, dos Reis FC, Puccia R, Travassos LR, Alviano CS (2003) Cleavage of human fibronectin and other basement membrane-associated proteins by a Cryptococcus neoformans Serine proteinase. Microb Pathog 34(2):65–71. 10.1016/s0882-4010(02)00195-x [DOI] [PubMed] [Google Scholar]
  • 46.Zarnowski R, Connolly PA, Wheat LJ, Woods JP (2007) Production of extracellular proteolytic activity by Histoplasma capsulatum grown in Histoplasma-macrophage medium is limited to restriction fragment length polymorphism class 1 isolates. Diagn Microbiol Infect Dis 59(1):39–47. 10.1016/j.diagmicrobio.2007.03.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Monod M (2008) Secreted proteases from dermatophytes. Mycopathologia 166(5–6):285–294. 10.1007/s11046-008-9105-4 [DOI] [PubMed] [Google Scholar]
  • 48.Lima CA, Rodrigues PMB, Porto TS, Viana DA, Lima Filho JL, Porto ALF et al (2009) Production of a collagenase from Candida albicans URM3622. Biochem Eng J 43(3):315–320. 10.1016/j.bej.2008.10.014 [Google Scholar]
  • 49.Vermelho AB, Mazotto AM, de Melo AC, Vieira FH, Duarte TR, Macrae A et al (2010) Identification of a Candida parapsilosis strain producing extracellular serine peptidase with keratinolytic activity. Mycopathologia 169(1):57–65. 10.1007/s11046-009-9231-7 [DOI] [PubMed] [Google Scholar]
  • 50.Palmeira VF, Kneipp LF, Rozental S, Alviano CS, Santos ALS (2008) Beneficial effects of HIV peptidase inhibitors on Fonsecaea pedrosoi: promising compounds to arrest key fungal biological processes and virulence. PLoS ONE 3(10):e3382. 10.1371/journal.pone.0003382 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Silva BA, Pinto MR, Soares RM, Barreto-Bergter E, Santos ALS (2006) Pseudallescheria boydii releases metallopeptidases capable of cleaving several proteinaceous compounds. Res Microbiol 157(5):425–432. 10.1016/j.resmic.2005.11.010 [DOI] [PubMed] [Google Scholar]
  • 52.Santos ALS, de Carvalho IM, da Silva BA, Portela MB, Alviano CS, Soares RMA (2006) Secretion of serine peptidase by a clinical strain of Candida albicans: influence of growth conditions and cleavage of human serum proteins and extracellular matrix components. FEMS Immunol Med Microbiol 46(2):209–220. 10.1111/j.1574-695X.2005.00023.x [DOI] [PubMed] [Google Scholar]
  • 53.Braga-Silva LA, Mogami SS, Valle RS, Silva-Neto ID, Santos ALS (2010) Multiple effects of amprenavir against Candida albicans. FEMS Yeast Res 10(2):221–224. 10.1111/j.1567-1364.2009.00595.x [DOI] [PubMed] [Google Scholar]
  • 54.Chimbekujwo KI, Ja’afaru MI, Adeyemo OM (2020) Purification, characterization and optimization conditions of protease produced by Aspergillus brasiliensis strain BCW2. Sci Afr 8. 10.1016/j.sciaf.2020.e00398
  • 55.Bezerra VHS, Cardoso SL, Fonseca-Bazzo Y, Silveira D, Magalhaes PO, Souza PM (2021) Protease produced by endophytic fungi: a systematic review. Molecules 26(22). 10.3390/molecules26227062 [DOI] [PMC free article] [PubMed]
  • 56.Brummer E, Restrepo A, Hanson LH, Stevens DA (1990) Virulence of Paracoccidiodes brasiliensis: the influence of in vitro passage and storage. Mycopathologia 109(1):13–17. 10.1007/BF00437001 [DOI] [PubMed] [Google Scholar]
  • 57.Morrison CJ, Stevens DA (1991) Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolates. Infect Immun 59(8):2744–2749. 10.1128/iai.59.8.2744-2749.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Peracoli MT, Sugizaki MF, Mendes RP, Naiff R, Montenegro MR (1999) Paracoccidioides brasiliensis isolated from armadillos is virulent to Syrian hamsters. Mycopathologia 148(3):123–130. 10.1023/a:1007119403572 [DOI] [PubMed] [Google Scholar]
  • 59.Arita GS, Faria DR, Sakita KM, Rodrigues-Vendramini FA, Capoci IR, Kioshima ES et al (2020) Impact of serial systemic infection on Candida albicans virulence factors. Future Microbiol 15:1249–1263. 10.2217/fmb-2019-0342 [DOI] [PubMed] [Google Scholar]
  • 60.Steenbergen JN, Nosanchuk JD, Malliaris SD, Casadevall A (2003) Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. Infect Immun 71(9):4862–4872. 10.1128/IAI.71.9.4862-4872.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Santos ALS, Braga-Silva LA, Goncalves DS, Ramos LS, Oliveira SSC, Souza LOP et al (2021) Repositioning lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans-in silico, in vitro and in vivo approaches. J Fungi (Basel) 7(6). 10.3390/jof7060424 [DOI] [PMC free article] [PubMed]
  • 62.Palmeira VF, Kneipp LF, Alviano CS, Santos ALS (2006) Secretory aspartyl peptidase activity from mycelia of the human fungal pathogen Fonsecaea pedrosoi: effect of HIV aspartyl proteolytic inhibitors. Res Microbiol 157(9):819–826. 10.1016/j.resmic.2006.07.003 [DOI] [PubMed] [Google Scholar]
  • 63.Gutierrez-Gongora D, Geddes-McAlister J (2021) From naturally-sourced protease inhibitors to new treatments for fungal infections. J Fungi (Basel) 7(12). 10.3390/jof7121016 [DOI] [PMC free article] [PubMed]
  • 64.Santos ALS (2011) Protease expression by microorganisms and its relevance to crucial physiological/pathological events. World J Biol Chem 2(3):48–58. 10.4331/wjbc.v2.i3.48 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Malinovska Z, Conkova E, Vaczi P (2023) Biofilm formation in medically important Candida species. J Fungi (Basel) 9(10). 10.3390/jof9100955 [DOI] [PMC free article] [PubMed]
  • 66.Winter MB, Salcedo EC, Lohse MB, Hartooni N, Gulati M, Sanchez H et al (2016) Global identification of biofilm-specific proteolysis in Candida albicans. mBio 7(5). 10.1128/mBio.01514-16 [DOI] [PMC free article] [PubMed]
  • 67.Feng W, Yang J, Ma Y, Liu Y, Yin R, Qiao Z et al (2022) Correlation between SAP2 and CAP1 in clinical strains of Candida albicans at planktonic and biofilm States. Can J Microbiol 68(12):722–730. 10.1139/cjm-2022-0139 [DOI] [PubMed] [Google Scholar]
  • 68.Nailis H, Kucharikova S, Ricicova M, Van Dijck P, Deforce D, Nelis H et al (2010) Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression. BMC Microbiol 10:114. 10.1186/1471-2180-10-114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Negri M, Silva S, Capoci IR, Azeredo J, Henriques M (2016) Candida tropicalis biofilms: biomass, metabolic activity and secreted aspartyl proteinase production. Mycopathologia 181(3–4):217–224. 10.1007/s11046-015-9964-4 [DOI] [PubMed] [Google Scholar]
  • 70.Feng W, Yang J, Ma Y, Zhang L, Yin R, Qiao Z et al (2023) Relationships between secreted aspartyl proteinase 2 and general control nonderepressible 4 gene in the Candida albicans resistant to Itraconazole under planktonic and biofilm conditions. Braz J Microbiol 54(2):619–627. 10.1007/s42770-023-00961-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Joo MY, Shin JH, Jang HC, Song ES, Kee SJ, Shin MG et al (2013) Expression of SAP5 and SAP9 in Candida albicans biofilms: comparison of bloodstream isolates with isolates from other sources. Med Mycol 51(8):892–896. 10.3109/13693786.2013.824623 [DOI] [PubMed] [Google Scholar]
  • 72.Mendes A, Mores AU, Carvalho AP, Rosa RT, Samaranayake LP, Rosa EA (2007) Candida albicans biofilms produce more secreted aspartyl protease than the planktonic cells. Biol Pharm Bull 30(9):1813–1815. 10.1248/bpb.30.1813 [DOI] [PubMed] [Google Scholar]
  • 73.Dutton LC, Jenkinson HF, Lamont RJ, Nobbs AH (2016) Role of Candida albicans secreted aspartyl protease Sap9 in interkingdom biofilm formation. Pathog Dis 74(3). 10.1093/femspd/ftw005 [DOI] [PMC free article] [PubMed]
  • 74.Kim JS, Lee KT, Bahn YS (2023) Secreted aspartyl protease 3 regulated by the ras/camp/pka pathway promotes the virulence of Candida auris. Front Cell Infect Microbiol 13:1257897. 10.3389/fcimb.2023.1257897 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Martinez-Garcia S, Rodriguez-Martinez S, Cancino-Diaz ME, Cancino-Diaz JC (2018) Extracellular proteases of Staphylococcus epidermidis: roles as virulence factors and their participation in biofilm. APMIS 126(3):177–185. 10.1111/apm.12805 [DOI] [PubMed] [Google Scholar]
  • 76.Ramirez-Larrota JS, Eckhard U (2022) An introduction to bacterial biofilms and their proteases, and their roles in host infection and immune evasion. Biomolecules 12(2). 10.3390/biom12020306 [DOI] [PMC free article] [PubMed]
  • 77.Lohse MB, Gulati M, Craik CS, Johnson AD, Nobile CJ (2020) Combination of antifungal drugs and protease inhibitors prevent Candida albicans biofilm formation and disrupt mature biofilms. Front Microbiol 11:1027. 10.3389/fmicb.2020.01027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Soldini S, Posteraro B, Vella A, De Carolis E, Borghi E, Falleni M et al (2018) Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality. Clin Microbiol Infect 24(7):771–777. 10.1016/j.cmi.2017.11.005 [DOI] [PubMed] [Google Scholar]
  • 79.Pannanusorn S, Ramirez-Zavala B, Lunsdorf H, Agerberth B, Morschhauser J, RomLing U (2014) Characterization of biofilm formation and the role of BCR1 in clinical isolates of Candida parapsilosis. Eukaryot Cell 13(4):438–451. 10.1128/EC.00181-13 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Brazilian Journal of Microbiology are provided here courtesy of Brazilian Society of Microbiology

RESOURCES